Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancerKRAMER, Henk; GROEN, Harry J. M.Annals of surgery. 2003, Vol 238, Num 2, pp 180-188, issn 0003-4932, 9 p.Article

Diagnosis of mediastinal and left adrenal abnormalities with endoscopic ultrasonographyKRAMER, Henk; GROEN, Harry J. M.Respiratory medicine. 2005, Vol 99, Num 7, pp 926-928, issn 0954-6111, 3 p.Article

Analysis of dry mesothelioma with ultrasound guided biopsiesSTIGT, Jos A; BOERS, James E; GROEN, Harry J. M et al.Lung cancer. 2012, Vol 78, Num 3, pp 229-233, issn 0169-5002, 5 p.Article

Respiratory medicineKERSTJENS, Huib A. M; GROEN, Harry J; VAN DER BIJ, Wim et al.BMJ. British medical journal (International ed.). 2001, Vol 323, Num 7325, pp 1349-1353, issn 0959-8146Article

Visualisation and assessment of the protein synthesis rate of lung cancer using carbon-11 tyrosine and positron emission tomographyPIETERMAN, Remge; WILLEMSEN, Antoon; APPEL, Milo et al.European journal of nuclear medicine. 2002, Vol 29, Num 2, pp 243-247, issn 0340-6997Article

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerPEIFER, Martin; FERNANDEZ-CUESTA, Lynnette; MENON, Roopika et al.Nature genetics. 2012, Vol 44, Num 10, pp 1104-1110, issn 1061-4036, 7 p.Article

Nodule management protocol of the NELSON randomised lung cancer screening trialDONG MING XU; GIETEMA, Hester; VAN KLAVEREN, Rob et al.Lung cancer. 2006, Vol 54, Num 2, pp 177-184, issn 0169-5002, 8 p.Article

Rare thoracic cancers, including peritoneum mesotheliomaSIESLING, Sabine; DER ZWAN, Jan Maarten Van; IZARZUGAZA, Isabel et al.European journal of cancer (1990). 2012, Vol 48, Num 7, pp 949-960, issn 0959-8049, 12 p.Article

Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review. Editorial CommentBRADBURY, Penelope A; SHEPHERD, Frances A; MANEGOLD, Christian et al.Lancet (British edition). 2007, Vol 369, Num 9577, issn 0140-6736, 1903-1904, 1929-1937 [11 p.]Article

Third-line chemotherapy for small cell lung cancerDE JONG, Wouter K; TEN HACKEN, Nick H. T; GROEN, Harry J. M et al.Lung cancer. 2006, Vol 52, Num 3, pp 339-342, issn 0169-5002, 4 p.Article

The prognostic value of positron emission tomography in non-small cell lung cancer : Analysis of 266 casesKRAMER, Henk; POST, Wendy J; PRUIM, Jan et al.Lung cancer. 2006, Vol 52, Num 2, pp 213-217, issn 0169-5002, 5 p.Article

Cardiotoxicity in advanced non-small cell lung cancer Patients treated with platinum and non-platinum based combinations as first-line treatmentWACHTERS, Floris M; VAN DER GRAAF, Winette T. A; GROEN, Harry J. M et al.Anticancer research. 2004, Vol 24, Num 3B, pp 2079-2083, issn 0250-7005, 5 p.Article

Promoter Methylation Primarily Occurs in Tumor Cells of Patients with Non-small Cell Lung CancerDE JONG, Wouter K; VERPOOTEN, Gonda F; KRAMER, Henk et al.Anticancer research. 2009, Vol 29, Num 1, pp 363-369, issn 0250-7005, 7 p.Article

Analysis of cytological specimens from mediastinal lesions obtained by endoscopic ultrasound-guided fine-needle aspirationKRAMER, Henk; SANDERS, Joyce; POST, Wendy J et al.Cancer. 2006, Vol 108, Num 4, pp 206-211, issn 0008-543X, 6 p.Article

Phase II study of docetaxel and carboplatin as second-line treatment in NSCLCWACHTERS, Floris M; VAN PUTTEN, John W. G; BOEZEN, H. Marike et al.Lung cancer. 2004, Vol 45, Num 2, pp 255-262, issn 0169-5002, 8 p.Article

End-joining deficiency and radiosensitization induced by gemcitabineVAN PUTTEN, John W. G; GROEN, Harry J. M; SMID, Kees et al.Cancer research (Baltimore). 2001, Vol 61, Num 4, pp 1585-1591, issn 0008-5472Article

JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatinFOKKEMA, Eelco; GROEN, Harry J. M; HELDER, Marco N et al.Biochemical pharmacology. 2002, Vol 63, Num 11, pp 1989-1996, issn 0006-2952Article

Expression and prognostic implications of apoptosis-related proteins in locally unresectable non-small cell lung cancersFOKKEMA, Eelco; TIMENS, Wim; DE VRIES, Elisabeth G. E et al.Lung cancer. 2006, Vol 52, Num 2, pp 241-247, issn 0169-5002, 7 p.Article

Extensive hepatic replacement due to liver metastases has no effect on 5-fluorouracil pharmacokineticsMARING, Jan Gerard; PIERSMA, Henk; VAN DALEN, Albert et al.Cancer chemotherapy and pharmacology. 2003, Vol 51, Num 2, pp 167-173, issn 0344-5704, 7 p.Article

Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancerVAN PUTTEN, John W. G; BAAS, Paul; CODRINGTON, Henk et al.Lung cancer. 2001, Vol 33, Num 2-3, pp 289-298, issn 0169-5002Article

Comparison of EUS-guided fine needle aspiration and integrated PET-CT in restaging after treatment for locally advanced non-small cell lung cancerSTIGT, Jos A; OOSTDIJK, Ad H; TIMMER, Paul R et al.Lung cancer. 2009, Vol 66, Num 2, pp 198-204, issn 0169-5002, 7 p.Article

Thymic epithelial tumours : A population-based study of the incidence, diagnostic procedures and therapyDE JONG, Wouter K; BLAAUWGEERS, Johannes L. G; SCHAAPUELD, Michael et al.European journal of cancer (1990). 2008, Vol 44, Num 1, pp 123-130, issn 0959-8049, 8 p.Article

Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumorsSPIERINGS, Diana C. J; DE VRIES, Elisabeth G. E; TIMENS, Wim et al.Clinical cancer research. 2003, Vol 9, Num 9, pp 3397-3405, issn 1078-0432, 9 p.Article

Gemcitabine and Epirubicin Plasma Concentration-Related Excretion in Saliva in Patients With Non-Small Cell Lung CancerMARING, Jan Gerard; WACHTERS, Floris M; MAURER, Marina et al.Therapeutic drug monitoring. 2010, Vol 32, Num 3, pp 364-368, issn 0163-4356, 5 p.Article

A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non―Small Cell Lung Cancer with a KRAS MutationDINGEMANS, Anne-Marie C; MELLEMA, Wouter W; GROEN, Harry J. M et al.Clinical cancer research (Print). 2013, Vol 19, Num 3, pp 743-751, issn 1078-0432, 9 p.Article